Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab.
Minohara K, Matoba T, Kawakita D, Takano G, Oguri K, Murashima A, Nakai K, Iwaki S, Hojo W, Matsumura A, Ozaki S, Ozawa T, Harata I, Tanaka N, Maseki S, Tsuge H, Imaizumi S, Mitsuya S, Moribe K, Esaki S, Iwasaki S.
Minohara K, et al. Among authors: matoba t.
Sci Rep. 2021 Aug 20;11(1):16992. doi: 10.1038/s41598-021-96538-7.
Sci Rep. 2021.
PMID: 34417539
Free PMC article.